Novo Nordisk's Wegovy, Fiasp, Ryzodeg Injectables Stolen During Transit, DCGI Issues Alert
New Delhi: The Drugs Controller General of India (DCGI) has issued an alert for doctors and healthcare professionals to carefully prescribe and educate the patients for reporting of any adverse drug reactions (ADRs) after pharmaceutical major Novo Nordisk reported the theft of multiple products of its critical rDNA-origin injectable medicines, including the popular weight loss drug semaglutide and the diabetes treatment insulin aspart, during transit from its Bhiwandi Hub to milk route (Nagpur, Raipur, Cuttack, and Kolkata).
The stolen products include widely used diabetes and obesity treatments such as Ryzodeg FlexTouch (insulin degludec/insulin aspart), Fiasp (insulin aspart) Penfill and FlexTouch, and Wegovy (semaglutide injections).
Novo Nordisk has raised a concern, citing, "The products under consideration are rDNA-origin injectables, which are required to be stored at 2-8°C. The quality of the products may be compromised if the products are not handled in proper storage conditions since the formulations are supposed to be maintained at 2°C to 8°C, failing which would impact the quality of the product and in turn impact the safety of the patients.
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.